These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 1954873

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effects of SMS 201-995 on basal and stimulated pancreatic secretion in rats.
    Guan D, Maouyo D, Sarfati P, Morisset J.
    Endocrinology; 1990 Jul; 127(1):298-304. PubMed ID: 2361474
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Importance of cholecystokinin in peptide-YY release in response to pancreatic juice diversion.
    Guan D, Rivard N, Maouyo D, Gettys TW, Morisset J.
    Regul Pept; 1993 Feb 18; 43(3):169-76. PubMed ID: 8441822
    [Abstract] [Full Text] [Related]

  • 5. Inhibitory effects of octreotide on luminal cholecystokinin-releasing factor, plasma cholecystokinin, and pancreatic secretion in conscious rats.
    Miyasaka K, Masuda M, Kanai S, Ohta M, Suzuki S, Tateishi K, Funakoshi A.
    Pancreas; 2002 Apr 18; 24(3):269-75. PubMed ID: 11893935
    [Abstract] [Full Text] [Related]

  • 6. Octreotide and cholecystokinin antagonist reduce edema in obstruction-induced acute pancreatitis.
    Toriumi Y, Samuel I, Wilcockson DP, Turkelson CM, Solomon TE, Joehl RJ.
    J Lab Clin Med; 1993 Oct 18; 122(4):450-4. PubMed ID: 8228560
    [Abstract] [Full Text] [Related]

  • 7. Inhibitory effect of somatostatin on cholecystokinin release is independent of luminal cholecystokinin-releasing factor content in conscious rats.
    Miyasaka K, Masuda M, Kanai S, Ohta M, Suzuki S, Tateishi K, Funakoshi A.
    Pancreas; 2001 Nov 18; 23(4):414-20. PubMed ID: 11668212
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Endogenous cholecystokinin, the major factor responsible for dietary protein-induced pancreatic growth.
    Morisset J, Guan D, Jurkowska G, Rivard N, Green GM.
    Pancreas; 1992 Nov 18; 7(5):522-9. PubMed ID: 1381095
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Evidence for autoregulation of cholecystokinin secretion during diversion of bile pancreatic juice in rats.
    Li Y, Hao Y, Owyang C.
    Gastroenterology; 1995 Jul 18; 109(1):231-8. PubMed ID: 7797020
    [Abstract] [Full Text] [Related]

  • 13. Interactions between bile and pancreatic juice diversions on cholecystokinin release and pancreas in conscious rats.
    Nakamura R, Miyasaka K, Funakoshi A, Kitani K.
    Proc Soc Exp Biol Med; 1989 Nov 18; 192(2):182-6. PubMed ID: 2813449
    [Abstract] [Full Text] [Related]

  • 14. Pancreatic atrophy in rats produced by the cholecystokinin-A receptor antagonist devazepide.
    Nylander AG, Chen D, Ihse I, Rehfeld JF, Håkanson R.
    Scand J Gastroenterol; 1992 Sep 18; 27(9):743-7. PubMed ID: 1411279
    [Abstract] [Full Text] [Related]

  • 15. Modulation of pancreatic secretion of individual digestive enzymes in octreotide (SMS 201-995)-infused rats.
    Maouyo D, Morisset J.
    Pancreas; 1997 Jan 18; 14(1):47-57. PubMed ID: 8981507
    [Abstract] [Full Text] [Related]

  • 16. Influence of CCK antagonist L-364,718, pancreastatin (33-49) and a somatostatin analogue on camostate-induced rat pancreatic hypertrophy.
    Schmidt WE, Stöckmann F, Choudhury AR, Wilms HM, Siegel EG, Nustede R, Fölsch UR, Creutzfeldt W.
    Digestion; 1989 Jan 18; 44(2):105-16. PubMed ID: 2612749
    [Abstract] [Full Text] [Related]

  • 17. Effects of endogenous and exogenous cholecystokinin and of infusion with the cholecystokinin antagonist L-364,718 on pancreatic and gastrointestinal growth.
    Axelson J, Håkanson R, Ihse I, Lilja I, Rehfeld JF, Sundler F.
    Scand J Gastroenterol; 1990 May 18; 25(5):471-80. PubMed ID: 2359975
    [Abstract] [Full Text] [Related]

  • 18. Soybean lectin stimulates pancreatic exocrine secretion via CCK-A receptors in rats.
    Jordinson M, Deprez PH, Playford RJ, Heal S, Freeman TC, Alison M, Calam J.
    Am J Physiol; 1996 Apr 18; 270(4 Pt 1):G653-9. PubMed ID: 8928795
    [Abstract] [Full Text] [Related]

  • 19. Pancreatic protein hypersecretion and elevated plasma CCK: prerequisites for increased pancreatic growth?
    Rivard N, Guan D, Maouyo D, Morisset J.
    Pancreas; 1993 Sep 18; 8(5):573-80. PubMed ID: 7508109
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.